Sapovirus IV

A negative bacterial stool culture leaves many viral causes of diarrhea untested. Sapovirus genogroup IV is one of them. This stool qPCR test looks for its genetic material and may help investigate unexplained diarrhea, particularly when illness persists in someone whose immune system is suppressed.

A positive result supports recent or ongoing infection, but it doesn't establish that this virus caused your symptoms. Sapovirus can remain detectable after recovery, occur without symptoms, and appear alongside another infection.

What the Test Detects

Sapovirus belongs to the Caliciviridae family, which also includes norovirus. Its genetic material is RNA. The four established human sapovirus genogroups are GI, GII, GIV, and GV; each contains genetically related viruses. This test targets GIV.

The specimen is stool, and the catalog specifies qPCR. Detecting this RNA virus by PCR requires first copying its RNA into DNA, which the assay then amplifies. This process is called reverse-transcription PCR. A quantitative assay estimates the amount of target genetic material from its signal and laboratory calibration.

The catalog lists CFU/g stool as the reporting unit. CFU stands for colony-forming units and ordinarily describes organisms grown in culture. That is not what viral qPCR measures. Without documentation explaining this assay's calibration, a result carrying that label cannot be interpreted as a count of infectious sapovirus or converted into published viral RNA quantities.

Sapovirus detection is established in clinical molecular stool panels. Using a separate GIV quantity to grade illness, choose treatment, or predict contagiousness remains unvalidated in the cited evidence. Studies of other assays do not establish the performance or clinical value of this particular quantitative result.

Acute Gastroenteritis

Sapovirus can cause watery diarrhea, vomiting, nausea, abdominal pain, and fever. Most illness in otherwise healthy people resolves without a virus-specific treatment, though dehydration can be serious. Symptoms overlap with those caused by norovirus and other intestinal infections.

Most estimates of disease burden combine several sapovirus genogroups. A meta-analysis of 106 studies found sapovirus in 3.4% of acute gastroenteritis cases. Detection reached 5.6% in studies using real-time reverse-transcription PCR. Differences in study populations and testing methods contributed to the variation; these figures are not estimates for GIV alone.

Local findings can differ substantially. A Spanish study detected sapovirus in about 16% of outpatient stool samples collected during acute gastroenteritis. Most characterized strains belonged to GI or GII, with GIV also present. That unusually high detection rate should not be treated as the expected chance of a positive result wherever you live.

Where Genogroup IV Fits

GI and GII dominate many surveys of individual gastroenteritis cases, but GIV can contribute substantially to particular outbreaks. Among hospitalized South African children, GIV accounted for 24% of characterized strains and was the most common individual genotype. GI strains collectively accounted for a larger share because several GI genotypes circulated.

GIV also has a documented role in adult outbreaks. In an investigation of previously unexplained, norovirus-negative outbreaks in Oregon and Minnesota, GIV caused about seven in ten of the outbreaks attributed to sapovirus. Many occurred in long-term care facilities. These outbreak findings do not describe the distribution of sapovirus in the general population.

Young Children and Repeat Infections

Sapovirus is a common cause of diarrhea in early childhood. A case-control analysis nested within a Peruvian birth cohort compared diarrheal and non-diarrheal stool samples. It estimated that sapovirus accounted for 7.1% of diarrhea episodes, rising to 13.2% during the second year of life. These estimates combined genogroups, including GIV.

Repeat infections with different strains occur in young children. In a Nicaraguan birth cohort, reinfection with the same genotype was uncommon, suggesting that protection after infection is partly genotype-specific. Prior infection therefore doesn't guarantee protection against another strain. These observations do not establish how long protection against GIV lasts.

Prolonged Infection When Immunity Is Suppressed

Sapovirus can cause persistent diarrhea in transplant recipients and other people with weakened immune defenses. One German hospital study found prolonged infections involving GI.2, GII.1, and GII.3, with stool detection lasting up to 119 days. This supports concern about persistent sapovirus infection, but it is evidence about other genogroups.

At an adult oncology center, sapovirus accounted for about one in ten people with a viral target detected on a gastrointestinal panel. Most illness was mild, but some transplant recipients had prolonged diarrhea and repeated positive tests, with detection extending to 495 days in one case. The panel combined sapovirus genogroups, so this duration cannot be assigned specifically to GIV.

Detection Without Symptoms

Asymptomatic detection is well documented, including for GIV. A Japanese outbreak investigation identified GIV in symptomatic students and in food handlers who had no gastrointestinal symptoms. Some asymptomatic adults had substantial amounts of viral RNA in stool.

Across studies combining sapovirus genogroups, the pooled detection rate in people without acute gastroenteritis was 2.7%. In the multinational MAL-ED childhood cohort, sapovirus appeared in 12.8% of routine surveillance stools. The frequency depends on age, setting, sampling, and assay sensitivity.

Higher amounts of stool RNA have been associated with diarrhea in some studies, including the Peruvian cohort. But those studies used their own assays and reporting methods. They do not supply a validated GIV quantity that separates symptomatic infection from symptom-free or post-illness detection in an individual.

How This Compares With Other Stool Testing

Routine bacterial stool culture and standard parasite microscopy do not detect sapovirus. Antigen tests detect only the organisms named in their target lists. Many clinical molecular gastrointestinal panels already include sapovirus, usually reporting GI, GII, GIV, and GV together as detected or not detected.

Performance belongs to the particular assay that was studied. A meta-analysis of FilmArray studies estimated that it detected about 96% of reference-positive sapovirus samples and classified about 99% of reference-negative samples as negative. Those findings concern combined sapovirus detection on that platform, not this GIV-specific quantitative assay.

When Results Can Be Misleading

A true RNA-positive result may reflect an infection that has already stopped causing symptoms. It may also accompany another pathogen that better explains the illness. PCR detects genetic material and does not directly measure whether the virus in the sample can infect another person.

False-positive and false-negative results also occur. In a 2026 study of stored specimens from a US Veterans Affairs surveillance network, CDC reference testing did not confirm 9 of 48 sapovirus-positive FilmArray results, or 18.8%. Confirmation required a positive result by either of two reference methods, not agreement between both. This finding concerns that study and platform; it is not the false-positive rate of this test.

Stool can contain substances that interfere with amplification. Sample handling, RNA extraction, and differences between viral sequences and the assay's targets can also affect detection. Laboratory controls help identify some of these problems, but the catalog does not specify this assay's control procedures or validation results.

Quantitative results depend on specimen preparation, calibration, and the amount of stool tested. A cycle threshold describes how many amplification rounds were needed to detect a signal; a lower threshold generally reflects more starting material within the same validated assay. Cycle thresholds and reported quantities from different laboratories are not directly interchangeable. This test's CFU/g stool label adds a further uncertainty until its calibration is explained.